.jpg)
Dan Scavilla has served as Globus Medical’s President and Chief Executive Officer since April 2022, leading Company’s acquisition of NuVasive, Inc. in an all-stock deal valued at $3 billion and integrating the two organizations to create the second largest spine technology company in the world. Dan serves on Globus Medical’s Board of Directors and is a member of the Nominating and Corporate Governance Committee. Previously, he served as Executive Vice President, Chief Commercial Officer and President, Trauma, where he scaled the Company’s manufacturing and distribution capabilities and launched the Orthopedics and Trauma business unit. Dan joined Globus Medical as Chief Financial Officer in 2015.
Prior to joining Globus Medical, Dan spent 28 years in increasing leadership roles within Johnson & Johnson (J&J), including serving as Chief Financial Officer, Global Vice President Finance & Business Operations of J&J Vision ($4 billion annual global revenue), and as Chief Financial Officer, Worldwide Vice President Finance of Advanced Sterilization Products—J&J’s infection prevention business within its MedTech business unit—helping to capture the number one market position in Sterilization. Additional roles at J&J include financial management positions at McNeil Consumer Healthcare (Kenvue), Centocor Biologics, and Cilag Schaffhausen Operations in Switzerland (Janssen Pharmaceutical).
Dan serves on the board of Dentsply Sirona (XRAY), the world’s largest manufacturer of professional dental products and technologies, and is a member of their Audit Committee. He served on the board of directors of Impulse Dynamics, a privately held medical technology company focused on minimally invasive treatment options for heart failure patients, from November 2021 to July 2023.
Dan received a B.S. in Finance and Organizational Behavior from LaSalle University and holds an MBA in International Management from Temple University.
Disclosure information not submitted.
Saturday, February 22, 2025
2:35 PM – 3:00 PM EST